Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Plos One|January 28, 2014
Multicountry burden of chronic hepatitis C viral infection among those aware of their diagnosis: a patient surveyMarco Dacosta Dibonaventura, Yong Yuan, Benedicte Lescrauwaet, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 7, 2015
Estimating the cost-effectiveness of daclatasvir plus asunaprevir in difficult to treat Japanese patients chronically infected with hepatitis C genotype 1bPhil McEwan, Thomas Ward, Samantha Webster, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 24, 2012
The burden of illness for patients with viral hepatitis C: evidence from a national survey in JapanGordon G Liu, Marco daCosta DiBonaventura, Yong Yuan, et al.
The Kobe Journal of Medical Sciences|September 14, 2012
Analysis of the 619 Brånemark System TiUnite implants: a retrospective studyYasuyuki Shibuya, Naoki Takata, Junichiro Takeuchi, et al.
International Journal of Radiation Oncology, Biology, Physics|April 7, 2009
Analysis of Vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nervesYusuke Demizu, Masao Murakami, Daisuke Miyawaki, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 29, 2004
What is next for pharmacoeconomics and outcomes research in Asia?Jim Doherty, Isao Kamae, Kenneth K C Lee, et al.
Journal of Atherosclerosis and Thrombosis|February 16, 2025
A Cost-Effectiveness Analysis for the Combination of Universal Screening at 9-10 Years Old and Reverse Cascade Screening of Relatives for Familial Hypercholesterolemia in JapanKeiji Matsunaga, Mariko Harada-Shiba, Shizuya Yamashita, et al.
Clinical Therapeutics|November 27, 2015
Cost-effectiveness Analysis of Apixaban against Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation in JapanIsao Kamae, Yoichiro Hashimoto, Yukihiro Koretsune, et al.
Annals of Internal Medicine|June 6, 2007
Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritisKunihiro Nishimura, Daisuke Sugiyama, Yoshinori Kogata, et al.
Value in Health Regional Issues|April 29, 2018
Estimating the Long-Term Clinical and Economic Outcomes of Daclatasvir Plus Asunaprevir in Difficult-to-Treat Japanese Patients Chronically Infected with Hepatitis C Genotype 1bPhil McEwan, Thomas Ward, Samantha Webster, et al.
Pageof 5